CFO Dominic Caruso said on an earnings call that ongoing reviews of the company's portfolio "suggest we currently have more opportunity to divest some nonstrategic businesses."
Integra announced in February its intent to acquire Codman Neurosurgery from Johnson & Johnson.
Integra hopes this deal will grow its revenue to $2 billion sooner than expected.
The company hopes the JNJ assets will give revenue growth a boost.
The company's shares hit $6.95 Wednesday midday.